Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The messenger's great message for vaccination
Steve Pascolo
Expert Review of Vaccines (2015) Vol. 14, Iss. 2, pp. 153-156
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

mRNA vaccines manufacturing: Challenges and bottlenecks
Sara Sousa Rosa, D.M.F. Prazeres, Ana M. Azevedo, et al.
Vaccine (2021) Vol. 39, Iss. 16, pp. 2190-2200
Open Access | Times Cited: 362
An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs
Margit Schnee, Annette B. Vogel, Daniel Voß, et al.
PLoS neglected tropical diseases (2016) Vol. 10, Iss. 6, pp. e0004746-e0004746
Open Access | Times Cited: 191
Poly(lactic acid) nanoparticles and cell-penetrating peptide potentiate mRNA-based vaccine expression in dendritic cells triggering their activation
Anne-Line Coolen, Céline Lacroix, Perrine Mercier‐Gouy, et al.
Biomaterials (2018) Vol. 195, pp. 23-37
Open Access | Times Cited: 164
The use of RNA-based treatments in the field of cancer immunotherapy
Mohammad Chehelgerdi, Matin Chehelgerdi
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 82
Evading innate immunity in nonviral mRNA delivery: don’t shoot the messenger
Joke Devoldere, Heleen Dewitte, Stefaan C. De Smedt, et al.
Drug Discovery Today (2015) Vol. 21, Iss. 1, pp. 11-25
Open Access | Times Cited: 98
mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown!
Vivek P. Chavda, Gargi Jogi, Srusti Dave, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 507-507
Open Access | Times Cited: 32
The paths toward non-viral CAR-T cell manufacturing: A comprehensive review of state-of-the-art methods
Yekta Metanat, Patrik Viktor, Ayesha Amajd, et al.
Life Sciences (2024) Vol. 348, pp. 122683-122683
Closed Access | Times Cited: 10
Recent innovations in mRNA vaccines
Jeffrey B. Ulmer, Andrew J Geall
Current Opinion in Immunology (2016) Vol. 41, pp. 18-22
Closed Access | Times Cited: 83
The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
Bruna Aparecida Souza Machado, Katharine Valéria Saraiva Hodel, Larissa Moraes dos Santos Fonseca, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1345-1345
Open Access | Times Cited: 41
A single immunization with core–shell structured lipopolyplex mRNA vaccine against rabies induces potent humoral immunity in mice and dogs
Jiawu Wan, Jianmei Yang, Zongmei Wang, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 18
An Aedes–Anopheles Vaccine Candidate Supplemented with BCG Epitopes Against the Aedes and Anopheles Genera to Overcome Hypersensitivity to Mosquito Bites
Muhammad Naveed, Urooj Ali, Tariq Aziz, et al.
Acta Parasitologica (2024) Vol. 69, Iss. 1, pp. 483-504
Closed Access | Times Cited: 6
Nucleic acid cancer vaccines targeting tumor related angiogenesis. Could mRNA vaccines constitute a game changer?
Srdan Tadic, Alfredo Martı́nez
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Immunity to Pathogens Taught by Specialized Human Dendritic Cell Subsets
Jens Geginat, Giulia Nizzoli, Moira Paroni, et al.
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 52
Introduction to RNA Vaccines
Thomas Kramps, Knut Elbers
Methods in molecular biology (2016), pp. 1-11
Closed Access | Times Cited: 49
Design of in vitro Transcribed mRNA Vectors for Research and Therapy
Marina Tusup, Lars E. French, Mara De Matos, et al.
CHIMIA International Journal for Chemistry (2019) Vol. 73, Iss. 5, pp. 391-391
Open Access | Times Cited: 44
Toward Microfluidic Continuous-flow and Intelligent Downstream Processing of Biopharmaceuticals
Vikas Sharma, Amirreza Mottafegh, Jeong‐Un Joo, et al.
Lab on a Chip (2024) Vol. 24, Iss. 11, pp. 2861-2882
Open Access | Times Cited: 5
RNA vaccines: The dawn of a new age for tuberculosis?
Junli Li, Dong Liu, Xiaochi Li, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Enhancing the performance of an in vitro RNA biosensor through iterative design of experiments
Rochelle Aw, Karen M. Polizzi
Biotechnology Progress (2025)
Open Access
mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions
Ryo Okuyama
Vaccines (2023) Vol. 11, Iss. 12, pp. 1737-1737
Open Access | Times Cited: 12
In Vitro-Transcribed (IVT)-mRNA CAR Therapy Development
Αndroulla N. Miliotou, Lefkothea C. Papadopoulou
Methods in molecular biology (2019), pp. 87-117
Closed Access | Times Cited: 29
Comparison of the Expression Kinetics and Immunostimulatory Activity of Replicating mRNA, Nonreplicating mRNA, and pDNA after Intradermal Electroporation in Pigs
Bregje Leyman, Hanne Huysmans, Séan Mc Cafferty, et al.
Molecular Pharmaceutics (2018) Vol. 15, Iss. 2, pp. 377-384
Closed Access | Times Cited: 28
The notorious R.N.A. in the spotlight - drug or target for the treatment of disease
Philipp Reautschnig, Paul Vogel, Thorsten Stafforst
RNA Biology (2016) Vol. 14, Iss. 5, pp. 651-668
Open Access | Times Cited: 27
Vaccines against COVID-19: Priority to mRNA-Based Formulations
Steve Pascolo
Cells (2021) Vol. 10, Iss. 10, pp. 2716-2716
Open Access | Times Cited: 22
Nanoparticle-based delivery platforms for mRNA vaccine development
Sezer Okay, Öznur Özge Özcan, Mesut Karahan
AIMS Biophysics (2020) Vol. 7, Iss. 4, pp. 323-338
Open Access | Times Cited: 21
Tackling pharmacological response heterogeneity by PBPK modeling to advance precision medicine productivity of nanotechnology and genomics therapeutics
Ioannis S. Vizirianakis, Αndroulla N. Miliotou, George A. Mystridis, et al.
Expert Review of Precision Medicine and Drug Development (2019) Vol. 4, Iss. 3, pp. 139-151
Closed Access | Times Cited: 19
Page 1 - Next Page

Scroll to top